Clinical spectrum and management of anterior scleritis: case reports.

IF 2.3 Q2 OPHTHALMOLOGY
Therapeutic Advances in Ophthalmology Pub Date : 2025-08-14 eCollection Date: 2025-01-01 DOI:10.1177/25158414251356374
Dominika Ördögh, Lilla Smeller, Dóra Júlia Szabó, Nicolette Sohár
{"title":"Clinical spectrum and management of anterior scleritis: case reports.","authors":"Dominika Ördögh, Lilla Smeller, Dóra Júlia Szabó, Nicolette Sohár","doi":"10.1177/25158414251356374","DOIUrl":null,"url":null,"abstract":"<p><p>Scleritis is a rare, potentially sight-threatening, painful eye disease. Based on its anatomical involvement, it can be categorized as anterior and posterior scleritis. There are several possible causes, among which infectious and noninfectious origins should be considered. From the therapeutic aspect, it is important to clarify the infectious origin, to provide target treatment, or to identify the possible underlying autoimmune disease. Corticosteroid therapy is considered to be the basis for the stepwise treatment of scleritis. In this article, we describe the management of three patients (investigations, stepwise approach of therapy, and treatment difficulties) who developed three different types of scleritis: anterior non-necrotizing scleritis, anterior necrotizing scleritis, and scleromalacia perforans. The differential diagnosis of scleritis and its management after diagnosis pose difficulties in clinical practice. In general, the therapeutic approach is based on the principle of early and individualized treatment, which depends on the nature and severity of the patient's inflammatory eye disease and the presence or absence of associated systemic diseases.</p>","PeriodicalId":23054,"journal":{"name":"Therapeutic Advances in Ophthalmology","volume":"17 ","pages":"25158414251356374"},"PeriodicalIF":2.3000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12357074/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Ophthalmology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/25158414251356374","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Scleritis is a rare, potentially sight-threatening, painful eye disease. Based on its anatomical involvement, it can be categorized as anterior and posterior scleritis. There are several possible causes, among which infectious and noninfectious origins should be considered. From the therapeutic aspect, it is important to clarify the infectious origin, to provide target treatment, or to identify the possible underlying autoimmune disease. Corticosteroid therapy is considered to be the basis for the stepwise treatment of scleritis. In this article, we describe the management of three patients (investigations, stepwise approach of therapy, and treatment difficulties) who developed three different types of scleritis: anterior non-necrotizing scleritis, anterior necrotizing scleritis, and scleromalacia perforans. The differential diagnosis of scleritis and its management after diagnosis pose difficulties in clinical practice. In general, the therapeutic approach is based on the principle of early and individualized treatment, which depends on the nature and severity of the patient's inflammatory eye disease and the presence or absence of associated systemic diseases.

Abstract Image

Abstract Image

Abstract Image

前巩膜炎的临床谱和治疗:病例报告。
巩膜炎是一种罕见的,潜在的视力威胁,痛苦的眼病。根据其解剖受累情况,可分为前巩膜炎和后巩膜炎。有几种可能的原因,其中应考虑传染性和非传染性来源。从治疗方面来说,明确感染来源、提供靶向治疗或确定可能的潜在自身免疫性疾病是很重要的。皮质类固醇治疗被认为是逐步治疗巩膜炎的基础。在这篇文章中,我们描述了三名患者的治疗方法(调查、逐步治疗方法和治疗困难),他们发展了三种不同类型的巩膜炎:前路非坏死性巩膜炎、前路坏死性巩膜炎和穿孔硬化。硬膜炎的鉴别诊断和诊断后的处理是临床实践中的难点。一般来说,治疗方法是基于早期和个体化治疗的原则,这取决于患者炎症性眼病的性质和严重程度以及是否存在相关的全身性疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.50
自引率
0.00%
发文量
44
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信